Update to Supply Disruption Alert on neuromuscular blocking agents: atracurium, cisatracurium and rocuronium

This update to SDA/2020/004(R) notes that the supply position on rocuronium has now substantially improved and therefore Trusts can now use it as a first-choice neuromuscular blocking agent. Supplies of atracurium and cisatracurium via the wholesalers remain severely limited.


Medicines and Healthcare products Regulatory Agency